These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15113045)

  • 41. Complete assignment of hyaluronan oligosaccharides up to hexasaccharides.
    Blundell CD; Reed MA; Almond A
    Carbohydr Res; 2006 Dec; 341(17):2803-15. PubMed ID: 17056022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exogenous hyaluronic acid enhances porcine parthenogenetic embryo development in vitro possibly mediated by CD44.
    Toyokawa K; Harayama H; Miyake M
    Theriogenology; 2005 Jul; 64(2):378-92. PubMed ID: 15955360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle.
    Yoshimura H; Muneta T; Nimura A; Yokoyama A; Koga H; Sekiya I
    Cell Tissue Res; 2007 Mar; 327(3):449-62. PubMed ID: 17053900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells.
    Joddar B; Ramamurthi A
    Biomaterials; 2006 May; 27(15):2994-3004. PubMed ID: 16457881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
    Jiang G; Park K; Kim J; Kim KS; Hahn SK
    Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronan in cytosol--microinjection-based probing of its existence and suggested functions.
    Siiskonen H; Rilla K; Kärnä R; Bart G; Jing W; Haller MF; DeAngelis PL; Tammi RH; Tammi MI
    Glycobiology; 2013 Feb; 23(2):222-31. PubMed ID: 23086746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentration and distribution of hyaluronic acid in mouse uterus throughout the estrous cycle.
    Teixeira Gomes RC; Verna C; Nader HB; dos Santos Simões R; Dreyfuss JL; Martins JR; Baracat EC; de Jesus Simões M; Soares JM
    Fertil Steril; 2009 Aug; 92(2):785-92. PubMed ID: 18930192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene expression, synthesis and degradation of hyaluronan during differentiation of 3T3-L1 adipocytes.
    Allingham PG; Brownlee GR; Harper GS; Pho M; Nilsson SK; Brown TJ
    Arch Biochem Biophys; 2006 Aug; 452(1):83-91. PubMed ID: 16824481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of HA mixed with adenovirus mediated rhBMP-2 transferred BMSCs of goats on distraction osteogenesis].
    Lin Z; Zhu Z; Tang T; Dai K; Lou J; Meng F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):134-8. PubMed ID: 18365605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of tumor metastasis in vivo by combination of paclitaxel and hyaluronic acid.
    Yin DS; Ge ZQ; Yang WY; Liu CX; Yuan YJ
    Cancer Lett; 2006 Nov; 243(1):71-9. PubMed ID: 16406327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
    Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
    J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia.
    Qiu J; Cheng R; Zhang J; Sun H; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2017 Oct; 18(10):3207-3214. PubMed ID: 28835099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biodistribution profiling of the chemical modified hyaluronic acid derivatives used for oral delivery system.
    Hsieh CM; Huang YW; Sheu MT; Ho HO
    Int J Biol Macromol; 2014 Mar; 64():45-52. PubMed ID: 24315950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy.
    Yang C; Liu Y; He Y; Du Y; Wang W; Shi X; Gao F
    Biomaterials; 2013 Sep; 34(28):6829-38. PubMed ID: 23764114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Large-scale preparation, purification, and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers.
    Tawada A; Masa T; Oonuki Y; Watanabe A; Matsuzaki Y; Asari A
    Glycobiology; 2002 Jul; 12(7):421-6. PubMed ID: 12122023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comprehensive model of hyaluronan turnover in the mouse.
    Jadin L; Bookbinder LH; Frost GI
    Matrix Biol; 2012 Mar; 31(2):81-9. PubMed ID: 22142621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome.
    Zhao F; Barber CJ; Sammani S; Wan L; Miller BW; Furenlid LR; Li Z; Gotur DB; Barrios R; Woolfenden JM; Martin DR; Liu Z
    Nucl Med Biol; 2022; 114-115():86-98. PubMed ID: 36270074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization of two host-guest associating hyaluronan derivatives.
    Soltés L; Mendichi R
    Biomed Chromatogr; 2003 Sep; 17(6):376-84. PubMed ID: 13680848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automated solid-phase synthesis of hyaluronan oligosaccharides.
    Walvoort MT; Volbeda AG; Reintjens NR; van den Elst H; Plante OJ; Overkleeft HS; van der Marel GA; Codée JD
    Org Lett; 2012 Jul; 14(14):3776-9. PubMed ID: 22780913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study.
    Gao F; Cao M; Yang C; He Y; Liu Y
    J Biomed Mater Res B Appl Biomater; 2006 Aug; 78(2):385-92. PubMed ID: 16544303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.